Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Share-based Compensation (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Share-based Compensation for 13 consecutive years, with $10.3 million as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation fell 8.91% year-over-year to $10.3 million; the TTM value through Mar 2026 reached $43.6 million, up 22.14%, while the annual FY2025 figure was $40.8 million, 37.38% up from the prior year.
  • Share-based Compensation hit $10.3 million in Q1 2026 for Viking Therapeutics, down from $12.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $13.5 million in Q2 2025 and bottomed at $893000.0 in Q4 2022.
  • Average Share-based Compensation over 5 years is $6.5 million, with a median of $7.1 million recorded in 2024.
  • Year-over-year, Share-based Compensation plummeted 47.47% in 2022 and then skyrocketed 336.73% in 2023.
  • Viking Therapeutics' Share-based Compensation stood at $893000.0 in 2022, then surged by 336.73% to $3.9 million in 2023, then soared by 112.82% to $8.3 million in 2024, then surged by 49.4% to $12.4 million in 2025, then fell by 16.64% to $10.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $10.3 million, $12.4 million, and $7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.